{"id":"NCT03400800","sponsor":"The Medicines Company","briefTitle":"Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol","officialTitle":"A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) or ACSVD Risk-Equivalents and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-01","primaryCompletion":"2019-07-31","completion":"2019-08-27","firstPosted":"2018-01-17","resultsPosted":"2020-08-21","lastUpdate":"2020-08-21"},"enrollment":1617,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["ASCVD","Risk Factor, Cardiovascular","Elevated Cholesterol"],"interventions":[{"type":"DRUG","name":"Inclisiran Sodium","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["Saline Solution"]}],"arms":[{"label":"Inclisiran","type":"EXPERIMENTAL"},{"label":"Saline Solution","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD or ASCVD-Risk equivalents and elevated LDL-C despite maximum tolerated dose of LDL-C lowering therapies to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) inclisiran injection(s). The study will be an international multicenter study (non-United States).","primaryOutcome":{"measure":"Percentage Change in LDL-C From Baseline to Day 510","timeFrame":"Baseline, Day 510","effectByArm":[{"arm":"Inclisiran","deltaMin":-49.3,"sd":null},{"arm":"Placebo","deltaMin":4.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":70,"countries":["Czechia","Germany","Hungary","Poland","South Africa","Ukraine","United Kingdom"]},"refs":{"pmids":["39093262","38063346","37282500","32187462"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":181,"n":811},"commonTop":["Diabetes mellitus","Nasopharyngitis","Hypertension","Upper respiratory tract infection","Arthralgia"]}}